Effects of First Wave of COVID-19 on Colon Cancer Multi-disciplinary Team Performance: A Two-Year Analysis: Effects of COVID-19 Outbreak on 2-year Outcomes of Colon Cancer Management

Background: We investigated the effects of COVID-19-related delay on two-year outcomes of colon cancer treatment during the first wave of the pandemic. Materials and Methods: Ninety-two patients were referred for bowel cancer at our National Health Service (NHS) trust between March and July 2020, an...

Full description

Saved in:
Bibliographic Details
Published in:Galen 2024-02, Vol.13, p.e3305
Main Authors: Kulkarni, Gaurav Vidyadhar, Kumaran, Narenkumar, Kelkar, Ashish Prabhakar
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page e3305
container_title Galen
container_volume 13
creator Kulkarni, Gaurav Vidyadhar
Kumaran, Narenkumar
Kelkar, Ashish Prabhakar
description Background: We investigated the effects of COVID-19-related delay on two-year outcomes of colon cancer treatment during the first wave of the pandemic. Materials and Methods: Ninety-two patients were referred for bowel cancer at our National Health Service (NHS) trust between March and July 2020, and 41 patients were treated for colon cancer and followed up (a two-year) through a multidisciplinary team (MDT). Treatment delays and overall survival (OS) were also assessed. Results: Treatment delays were observed in 48% of patients. The average delay was 31 days beyond the 62-day mark (P
doi_str_mv 10.31661/gmj.v13i.3305
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_31661_gmj_v13i_3305</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_31661_gmj_v13i_3305</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_31661_gmj_v13i_33053</originalsourceid><addsrcrecordid>eNqVj89KxDAQxoMouOhePc8LpCYZ2u56W-ouehA9lF08hVATSUmbJVNX9u1txBfw8v2BbwZ-jN1JUaCsKnn_OfTFSaIvEEV5wRYKleIK6_XlnMvViqu6qq_ZkqgXQkiJiFW5YP3WOdtNBNHBziea4GBONrfmdf_8yOUa4ghNDFnN2NkEL19h8vzDU-ePwY8mnaG1ZoA3m1xMQx49wAba78jfrUmwGU04k6dbduVMILv88xtW7LZt88S7FImSdfqY_DC_01LoXyg9Q-kMpTMU_vvgB6ShVNY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effects of First Wave of COVID-19 on Colon Cancer Multi-disciplinary Team Performance: A Two-Year Analysis: Effects of COVID-19 Outbreak on 2-year Outcomes of Colon Cancer Management</title><source>PubMed Central</source><creator>Kulkarni, Gaurav Vidyadhar ; Kumaran, Narenkumar ; Kelkar, Ashish Prabhakar</creator><creatorcontrib>Kulkarni, Gaurav Vidyadhar ; Kumaran, Narenkumar ; Kelkar, Ashish Prabhakar</creatorcontrib><description>Background: We investigated the effects of COVID-19-related delay on two-year outcomes of colon cancer treatment during the first wave of the pandemic. Materials and Methods: Ninety-two patients were referred for bowel cancer at our National Health Service (NHS) trust between March and July 2020, and 41 patients were treated for colon cancer and followed up (a two-year) through a multidisciplinary team (MDT). Treatment delays and overall survival (OS) were also assessed. Results: Treatment delays were observed in 48% of patients. The average delay was 31 days beyond the 62-day mark (P&lt;0.001). Logistic and binary logistic regression models showed that a comorbid diagnosis of respiratory disease had a significant effect on delays in management and two-year outcomes (P=0.04), but without the likelihood of upstaging or a poorer outcome (P=0.942). The overall survival rate was 81.5%. Eight percent of bowel cancer surgeries could have been avoided if endoscopic visualization and biopsy were available, and 8% more surgeries could have been performed laparoscopically without fear of surrounding aerosols. Conclusion: The findings showed that oncologic care provided minimal disruption to trust during the COVID-19 pandemic owing to a quick association between the NHS site and a green non-NHS site, resulting in acceptable two-year outcomes for colon cancer patients.</description><identifier>ISSN: 2588-2767</identifier><identifier>EISSN: 2322-2379</identifier><identifier>DOI: 10.31661/gmj.v13i.3305</identifier><language>eng</language><ispartof>Galen, 2024-02, Vol.13, p.e3305</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Kulkarni, Gaurav Vidyadhar</creatorcontrib><creatorcontrib>Kumaran, Narenkumar</creatorcontrib><creatorcontrib>Kelkar, Ashish Prabhakar</creatorcontrib><title>Effects of First Wave of COVID-19 on Colon Cancer Multi-disciplinary Team Performance: A Two-Year Analysis: Effects of COVID-19 Outbreak on 2-year Outcomes of Colon Cancer Management</title><title>Galen</title><description>Background: We investigated the effects of COVID-19-related delay on two-year outcomes of colon cancer treatment during the first wave of the pandemic. Materials and Methods: Ninety-two patients were referred for bowel cancer at our National Health Service (NHS) trust between March and July 2020, and 41 patients were treated for colon cancer and followed up (a two-year) through a multidisciplinary team (MDT). Treatment delays and overall survival (OS) were also assessed. Results: Treatment delays were observed in 48% of patients. The average delay was 31 days beyond the 62-day mark (P&lt;0.001). Logistic and binary logistic regression models showed that a comorbid diagnosis of respiratory disease had a significant effect on delays in management and two-year outcomes (P=0.04), but without the likelihood of upstaging or a poorer outcome (P=0.942). The overall survival rate was 81.5%. Eight percent of bowel cancer surgeries could have been avoided if endoscopic visualization and biopsy were available, and 8% more surgeries could have been performed laparoscopically without fear of surrounding aerosols. Conclusion: The findings showed that oncologic care provided minimal disruption to trust during the COVID-19 pandemic owing to a quick association between the NHS site and a green non-NHS site, resulting in acceptable two-year outcomes for colon cancer patients.</description><issn>2588-2767</issn><issn>2322-2379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVj89KxDAQxoMouOhePc8LpCYZ2u56W-ouehA9lF08hVATSUmbJVNX9u1txBfw8v2BbwZ-jN1JUaCsKnn_OfTFSaIvEEV5wRYKleIK6_XlnMvViqu6qq_ZkqgXQkiJiFW5YP3WOdtNBNHBziea4GBONrfmdf_8yOUa4ghNDFnN2NkEL19h8vzDU-ePwY8mnaG1ZoA3m1xMQx49wAba78jfrUmwGU04k6dbduVMILv88xtW7LZt88S7FImSdfqY_DC_01LoXyg9Q-kMpTMU_vvgB6ShVNY</recordid><startdate>20240226</startdate><enddate>20240226</enddate><creator>Kulkarni, Gaurav Vidyadhar</creator><creator>Kumaran, Narenkumar</creator><creator>Kelkar, Ashish Prabhakar</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20240226</creationdate><title>Effects of First Wave of COVID-19 on Colon Cancer Multi-disciplinary Team Performance: A Two-Year Analysis</title><author>Kulkarni, Gaurav Vidyadhar ; Kumaran, Narenkumar ; Kelkar, Ashish Prabhakar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_31661_gmj_v13i_33053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kulkarni, Gaurav Vidyadhar</creatorcontrib><creatorcontrib>Kumaran, Narenkumar</creatorcontrib><creatorcontrib>Kelkar, Ashish Prabhakar</creatorcontrib><collection>CrossRef</collection><jtitle>Galen</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kulkarni, Gaurav Vidyadhar</au><au>Kumaran, Narenkumar</au><au>Kelkar, Ashish Prabhakar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of First Wave of COVID-19 on Colon Cancer Multi-disciplinary Team Performance: A Two-Year Analysis: Effects of COVID-19 Outbreak on 2-year Outcomes of Colon Cancer Management</atitle><jtitle>Galen</jtitle><date>2024-02-26</date><risdate>2024</risdate><volume>13</volume><spage>e3305</spage><pages>e3305-</pages><issn>2588-2767</issn><eissn>2322-2379</eissn><abstract>Background: We investigated the effects of COVID-19-related delay on two-year outcomes of colon cancer treatment during the first wave of the pandemic. Materials and Methods: Ninety-two patients were referred for bowel cancer at our National Health Service (NHS) trust between March and July 2020, and 41 patients were treated for colon cancer and followed up (a two-year) through a multidisciplinary team (MDT). Treatment delays and overall survival (OS) were also assessed. Results: Treatment delays were observed in 48% of patients. The average delay was 31 days beyond the 62-day mark (P&lt;0.001). Logistic and binary logistic regression models showed that a comorbid diagnosis of respiratory disease had a significant effect on delays in management and two-year outcomes (P=0.04), but without the likelihood of upstaging or a poorer outcome (P=0.942). The overall survival rate was 81.5%. Eight percent of bowel cancer surgeries could have been avoided if endoscopic visualization and biopsy were available, and 8% more surgeries could have been performed laparoscopically without fear of surrounding aerosols. Conclusion: The findings showed that oncologic care provided minimal disruption to trust during the COVID-19 pandemic owing to a quick association between the NHS site and a green non-NHS site, resulting in acceptable two-year outcomes for colon cancer patients.</abstract><doi>10.31661/gmj.v13i.3305</doi></addata></record>
fulltext fulltext
identifier ISSN: 2588-2767
ispartof Galen, 2024-02, Vol.13, p.e3305
issn 2588-2767
2322-2379
language eng
recordid cdi_crossref_primary_10_31661_gmj_v13i_3305
source PubMed Central
title Effects of First Wave of COVID-19 on Colon Cancer Multi-disciplinary Team Performance: A Two-Year Analysis: Effects of COVID-19 Outbreak on 2-year Outcomes of Colon Cancer Management
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T21%3A15%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20First%20Wave%20of%20COVID-19%20on%20Colon%20Cancer%20Multi-disciplinary%20Team%20Performance:%20A%20Two-Year%20Analysis:%20Effects%20of%20COVID-19%20Outbreak%20on%202-year%20Outcomes%20of%20Colon%20Cancer%20Management&rft.jtitle=Galen&rft.au=Kulkarni,%20Gaurav%20Vidyadhar&rft.date=2024-02-26&rft.volume=13&rft.spage=e3305&rft.pages=e3305-&rft.issn=2588-2767&rft.eissn=2322-2379&rft_id=info:doi/10.31661/gmj.v13i.3305&rft_dat=%3Ccrossref%3E10_31661_gmj_v13i_3305%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_31661_gmj_v13i_33053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true